The Powerball jackpot is now at $1.6 billion for the Monday, Dec. 22 drawing after no ticket matched all six numbers following a drawing on Dec. 20. The jackpot, with an estimated cash value of $753.3 ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
2 billion-dollar lottery jackpots for Mega Millions and Powerball were purchased at a Florida Publix. The amount? $1.58 billion and $1.586 billion. In Florida, stores that sell winning Mega Millions ...
One person that helped bring the chill was an analyst cutting his price target. Another two were executives at the biotech selling chunks of stock. The company was the target of an analyst price ...
Microsoft’s Copilot generative AI is popping up on the web, in mobile apps, in the Edge browser, and especially in Windows. But just what exactly is it? Here’s everything you need to know. I've been ...
A cinematic obsessive with the filmic palate of a starving raccoon, Rob London will watch pretty much anything once. With a mind like a steel trap, he's an endless fount of movie and TV trivia, borne ...
Zero-sum thinking is outdated. The future of growth is inclusive, abundant and collective. Unsplash+ Our economic narrative has been hijacked by a dangerous falsehood: the notion that the economy is ...
Paolo Bicchieri is the associate editor for the Northern California and Pacific Northwest region writing about restaurant and bar trends, coffee and cafes, and pop-ups. If you ask us, the best dim sum ...
Recursion Pharmaceuticals' stock has been volatile, and is soaring today on news the FDA is planning on phasing out some animal testing, replacing it with AI. The company's Q4 FY24 earnings showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback